DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,641,165 | +13.4% | 38,860 | +9.7% | 0.46% | +16.8% |
| Q2 2023 | $8,505,360 | +136.3% | 35,439 | +148.2% | 0.39% | +106.3% |
| Q1 2023 | $3,599,130 | -6.3% | 14,280 | -1.3% | 0.19% | -5.9% |
| Q4 2022 | $3,840,892 | +3.3% | 14,471 | +0.5% | 0.20% | -6.5% |
| Q3 2022 | $3,719,000 | +2.9% | 14,400 | +1.0% | 0.22% | +6.9% |
| Q2 2022 | $3,615,000 | -13.8% | 14,262 | -0.2% | 0.20% | -6.5% |
| Q1 2022 | $4,192,000 | -5.2% | 14,292 | +6.4% | 0.22% | -6.5% |
| Q4 2021 | $4,420,000 | +311.2% | 13,436 | +280.4% | 0.23% | +262.5% |
| Q3 2021 | $1,075,000 | +16.1% | 3,532 | +2.4% | 0.06% | +14.3% |
| Q2 2021 | $926,000 | +19.0% | 3,450 | -0.3% | 0.06% | +9.8% |
| Q1 2021 | $778,000 | +4.6% | 3,459 | +3.3% | 0.05% | 0.0% |
| Q4 2020 | $744,000 | +1.5% | 3,350 | -1.6% | 0.05% | -10.5% |
| Q3 2020 | $733,000 | +21.4% | 3,405 | -0.4% | 0.06% | +11.8% |
| Q2 2020 | $604,000 | +29.9% | 3,419 | +1.8% | 0.05% | +10.9% |
| Q1 2020 | $465,000 | -16.8% | 3,357 | -7.8% | 0.05% | +2.2% |
| Q4 2019 | $559,000 | +7.1% | 3,641 | +0.8% | 0.04% | -4.3% |
| Q3 2019 | $522,000 | -3.9% | 3,611 | -5.0% | 0.05% | -7.8% |
| Q2 2019 | $543,000 | +8.2% | 3,801 | 0.0% | 0.05% | +2.0% |
| Q1 2019 | $502,000 | +26.8% | 3,801 | -1.1% | 0.05% | +13.6% |
| Q4 2018 | $396,000 | -9.8% | 3,842 | -4.9% | 0.04% | -2.2% |
| Q3 2018 | $439,000 | +10.6% | 4,042 | +0.4% | 0.04% | +2.3% |
| Q2 2018 | $397,000 | +0.5% | 4,025 | 0.0% | 0.04% | -2.2% |
| Q1 2018 | $395,000 | +1.8% | 4,025 | -3.6% | 0.04% | +4.7% |
| Q4 2017 | $388,000 | -15.3% | 4,177 | -21.6% | 0.04% | -18.9% |
| Q3 2017 | $458,000 | +10.4% | 5,331 | +8.5% | 0.05% | +3.9% |
| Q2 2017 | $415,000 | +11.3% | 4,915 | +12.9% | 0.05% | +6.2% |
| Q1 2017 | $373,000 | -14.4% | 4,352 | -22.2% | 0.05% | -21.3% |
| Q4 2016 | $436,000 | -25.6% | 5,594 | -25.2% | 0.06% | -30.7% |
| Q3 2016 | $586,000 | -56.5% | 7,475 | -44.0% | 0.09% | -57.5% |
| Q2 2016 | $1,348,000 | +11.2% | 13,348 | +4.4% | 0.21% | +11.3% |
| Q1 2016 | $1,212,000 | -9.7% | 12,782 | -11.5% | 0.19% | -12.3% |
| Q4 2015 | $1,342,000 | +3.7% | 14,447 | -4.8% | 0.21% | -4.5% |
| Q3 2015 | $1,294,000 | -1.1% | 15,183 | -0.7% | 0.22% | +5.7% |
| Q2 2015 | $1,309,000 | +7.6% | 15,283 | +6.7% | 0.21% | +1.0% |
| Q1 2015 | $1,216,000 | +3.6% | 14,319 | +4.5% | 0.21% | -0.5% |
| Q4 2014 | $1,174,000 | +2.0% | 13,699 | -9.5% | 0.21% | -4.1% |
| Q3 2014 | $1,151,000 | +8.0% | 15,143 | +11.9% | 0.22% | +5.8% |
| Q2 2014 | $1,066,000 | +7.9% | 13,538 | +2.8% | 0.21% | +16.4% |
| Q1 2014 | $988,000 | -12.8% | 13,166 | -10.3% | 0.18% | -14.1% |
| Q4 2013 | $1,133,000 | -44.5% | 14,679 | -50.2% | 0.21% | +0.5% |
| Q3 2013 | $2,040,000 | +123.9% | 29,456 | +104.7% | 0.20% | +9.6% |
| Q2 2013 | $911,000 | – | 14,390 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |